drugset / Trial / NCT06215820
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after bunionectomy.
Timeline
- Start
- 2023-12-29
- Primary completion
- 2024-08-24
- Completion
- 2024-09-30
Outcome
Met primary endpoint
release “bunionectomy: LS mean difference in SPID 0-48h between MR-107A-02 and placebo = 82.7 (95% CI: 62.0, 103.4; p <0.001)” viatris.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MR-107A-02 | Unknown | 15 mg | — |
| Comparator | Tramadol | Other / unclassified | 50 mg | — |
Indications
No indication recorded.